Member Fee £150 (*€190) (Join Now) / Non-Member Fee £300 (*€376)
Virtual half-day meeting (Via Zoom) on:
USP Chapter <86> and the move to recombinant methods
29th April 2025 12.00 – 16.00 (BST)
The final text of the chapter has been published and will become official in May 2025.
What does this mean to you?
Attend this virtual meeting and hear from Eli Lilly and AstraZeneca on their approaches
PLUS
To move or not to move? Hear presentations from several endotoxin companies who will provide an overview of their technology that meets USP<86> and, what is covered in their supplier validation packages to help you make that informed choice.
Take a look at the detailed agenda attached which also includes a booking form
